The goal of this program is to improve management of myelodysplastic syndrome (MDS) and gastrointestinal (GI) malignancies. After hearing and assimilating this program, the clinician will be better able to: 1. Recognize the presenting clinical and pathologic features of MDS. 2. Analyze the risks and benefits of various supportive care measures for the management of MDS. 3. Understand changes to the diagnostic criteria and classification systems for MDS. 4. Devise evidence-based therapeutic strategies for the management of patients with low-risk or high-risk MDS. 5. Evaluate the role of adjuvant and neoadjuvant immunotherapy in the management of GI malignancies.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-04-11 05:00:00
- End Date: 2023-04-11 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest